Yasmeen Khan, M.D
NPI 1386811222 · Allergy & Immunology Physician · Fort Lauderdale, FL
Enrolled with Medicare as Practitioner - Allergy/Immunology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1386811222
- Entity type
- Individual
- Primary specialty
- Allergy & Immunology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D
- Sex
- Female
- Sole proprietor
- Yes
- License
- ME116699 (FL)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
18 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
1,786 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Test for Allergy Using Allergenic Extract95004 | 827 | $4 |
| Professional Service for Preparation and Provision of 1 Or More Antigens95165 | 390 | $15 |
| Professional Service for Multiple Injections of Allergen95117 | 350 | $12 |
| Administration and Interpretation of Patient-Focused Health Risk Assessment96160 | 51 | $3 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 42 | $129 |
| Test to Measure the Level of Nitric Oxide Gas95012 | 34 | $19 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 15 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Fluticasone/Umeclidin/Vilanterbrand: Trelegy Ellipta | 97 | 30 |
| Fluticasone Propionate | 85 | 39 |
| Montelukast Sodium | 68 | 22 |
| Albuterol Sulfatebrand: Albuterol Sulfate Hfa | 39 | 22 |
| Levocetirizine Dihydrochloride | 33 | 12 |
| Fluticasone/Vilanterolbrand: Breo Ellipta | 32 | — |
| Omeprazole |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$1,152 across 43 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2008-05-09
- Last updated
- 2014-04-15
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.